Review
Biochemistry & Molecular Biology
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Hisayuki Katsuyama
Summary: Randomized controlled trials have shown that reducing LDL-C with statins significantly decreases the risk of developing cardiovascular disease (CVD). However, a considerable number of patients still have residual CVD risk despite statin therapy, particularly in the high-dose statin arms. Elevated TG levels, reduced HDL-C, obesity/insulin resistance, and diabetes are important metabolic factors associated with statin residual CVD risk. Lipoprotein (a), remnant lipoproteins, MDA-LDL, and Sd-LDL play key roles in atherosclerosis and could provide new targets for reducing CVD events in patients receiving statins.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Hematology
Jing-Wei Gao, Si You, Zhao-Yu Liu, Qing-Yun Hao, Jing-Feng Wang, Dominique A. Vuitton, Shao-Ling Zhang, Pin-Ming Liu
Summary: The study found that metabolically healthy obesity (MHO) is associated with an increased risk of coronary artery calcium (CAC) progression and subsequent cardiovascular disease events. However, MHO individuals have a lower risk of cardiovascular disease compared to metabolically healthy individuals with normal weight.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
(2022)
Article
Multidisciplinary Sciences
Elias Bjornson, Dimitrios Samaras, Martin Adiels, Joel Kullberg, Fredrik Backhed, Goeran Bergstrom, Anders Gummesson
Summary: Non-alcoholic fatty liver disease (NAFLD) is associated with increased risk of coronary heart disease (CHD). ApoB-containing lipoproteins, including LDLs and TRLs, mediate a portion of the increased risk of atherosclerosis in people with NAFLD. Mediation analysis in a cohort of middle aged individuals showed that apoB, plasma triglycerides, and TRL-cholesterol mediate a significant proportion of the association between liver fat and coronary artery calcium score (CACS), with a higher degree of mediation observed for TRLs compared to LDLs. These results highlight the potential role of TRL-lowering in reducing NAFLD-associated coronary artery disease risk.
SCIENTIFIC REPORTS
(2023)
Article
Cardiac & Cardiovascular Systems
Anurag Mehta, Nestor Vasquez, Colby R. Ayers, Jaideep Patel, Ananya Hooda, Amit Khera, Roger S. Blumenthal, Michael D. Shapiro, Carlos J. Rodriguez, Michael Y. Tsai, Laurence S. Sperling, Salim S. Virani, Michael J. Blaha, Parag H. Joshi
Summary: Elevated lipoprotein(a) and coronary artery calcium are independently associated with ASCVD risk, and may be concurrently useful in guiding primary prevention therapy decisions, as demonstrated in the MESA and DHS cohorts.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Harold Superko, Brenda Garrett
Summary: Despite statin use and LDL-C reduction, residual cardiovascular disease event risk remains. Abnormal lipoprotein size and density distribution, known as lipoprotein heterogeneity, contributes to this residual risk. Recent clinical trial evidence reinforces the importance of LDL heterogeneity measurement and its impact on CHD risk prediction and outcomes.
Article
Peripheral Vascular Disease
Hui-Wen Zhang, Jing-Lu Jin, Ye-Xuan Cao, Hui-Hui Liu, Yan Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Ying Gao, Rui-Xia Xu, Qi Hua, Yan-Fang Li, Chuan-Jue Cui, Qian Dong, Jing Sun, Jian-Jun Li
Summary: This study found that sdLDL-C levels are associated with disease severity and worse outcomes in hypertensive patients with CAD. In hypertensive patients with poorly controlled hypertension, higher sdLDL-C levels were independently associated with CVEs. Paying more attention to sdLDL-C in these patients may be warranted.
JOURNAL OF HYPERTENSION
(2021)
Article
Hematology
Ki-Chul Sung, Tae Kyung Yoo, Mi Yeon Lee, Christopher D. Byrne, Ming-Hua Zheng, Giovanni Targher
Summary: In this study, both NAFLD and MAFLD were found to be significantly associated with an increased risk of prevalent and incident CAC. The association was stronger for MAFLD compared to NAFLD.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Ali A. Rizvi, Anca Pantea Stoian, Andrej Janez, Manfredi Rizzo
Summary: Dyslipidemia is a significant risk factor for cardiovascular disease, with small, dense LDL being the most predictive subtype for atherosclerosis and cardiovascular events. In addition to traditional lipid-lowering therapies, certain novel treatments such as GLP1-RAs have shown potential benefits in impacting sdLDL and reducing cardiovascular risk. Further research is warranted to explore their beneficial non-glycemic effects.
Article
Cardiac & Cardiovascular Systems
Jie Gao, Jun Lu, Wenjun Sha, Bilin Xu, Cuiping Zhang, Hongping Wang, Juan Xia, Hong Zhang, Wenjun Tang, Tao Lei
Summary: This study evaluated the association between the neutrophil to HDL-C ratio (NHR) and the degree of coronary stenosis in patients with stable coronary artery disease (CAD). The results showed that NHR was not only associated with the occurrence and seriousness of CAD, but also a better predictor of severe CAD than neutrophil, HDL-C or LDL-C/HDL-C.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Hiroaki Ikezaki, Elise Lim, L. Adrienne Cupples, Ching-Ti Liu, Bela F. Asztalos, Ernst J. Schaefer
Summary: This study showed that small dense LDL-C, direct LDL-C, and lipoprotein(a) are significantly associated with ASCVD risk, with small dense LDL being the most atherogenic lipoprotein parameter.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2021)
Article
Cardiac & Cardiovascular Systems
Ya Li, Yujia Feng, Shu Li, Yulin Ma, Jiesheng Lin, Jing Wan, Min Zhao
Summary: The aim of this study was to investigate the correlation between the atherogenic index of plasma (AIP) and the severity of coronary artery disease (CAD). The results showed that AIP, AI, and LCI were positively correlated with the severity of CAD. CRI I, CRI II, AIP, AI, and LCI could be used as biomarkers for the evaluation of CAD severity.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2023)
Article
Biochemistry & Molecular Biology
Dorina Ibi, Manon Boot, Martijn E. T. Doll, J. Wouter Jukema, Frits R. Rosendaal, Constantinos Christodoulides, Matt J. Neville, Robert Koivula, Patrick C. N. Rensen, Fredrik Karpe, Raymond Noordam, Ko Willems van Dijk
Summary: Variations in the APOA5 and LPL genes that result in lower TG levels are associated with a reduced risk of coronary artery disease. APOA5 gene variation has a significant impact on TG levels and lipoprotein profile. These findings suggest that APOA5 may be a potential novel therapeutic target for CAD prevention.
JOURNAL OF LIPID RESEARCH
(2022)
Article
Medical Laboratory Technology
Karol M. Pencina, Michael J. Pencina, Patrick R. Lawler, James C. Engert, Line Dufresne, Paul M. Ridker, George Thanassoulis, Samia Mora, Allan D. Sniderman
Summary: This study examines the interplay of apolipoprotein B (apoB) and LDL particle size in the risk of new-onset coronary heart disease (CHD). The results show that apoB is a strong risk factor for CHD, but the association between cholesterol-depleted LDL particles and CHD remains inconclusive.
CLINICAL CHEMISTRY
(2023)
Article
Medicine, General & Internal
Haci Ali Kurklu, Turkan Seda Tan, Nil Ozyuncu, Emir Baskovski, Cagdas Ozdol
Summary: The study suggests that the atherogenic index of plasma (AIP) is an effective parameter for estimating obstructive coronary artery disease (CAD). AIP values above 0.49 indicate a 50% stenosis of coronary arteries.
Article
Multidisciplinary Sciences
Yen-Wei Li, Tung-Wei Kao, Pi-Kai Chang, Wei-Liang Chen, Li-Wei Wu
Summary: The study found that the atherogenic index of plasma (AIP) was significantly associated with MetS, hypertension, and T2DM in different genders and age groups, especially prominent in the middle-aged population. For participants aged 40-64, AIP remained significantly correlated with MetS, hypertension, and T2DM even after full adjustment, while for those aged above 65, AIP only showed significant association in the MetS group.
SCIENTIFIC REPORTS
(2021)
Article
Pharmacology & Pharmacy
Romeo Ngoune, Christine Contini, Michael M. Hoffmann, Dominik von Elverfeldt, Karl Winkler, Gerhard Puetz
CURRENT DRUG DELIVERY
(2018)
Review
Cardiac & Cardiovascular Systems
Michael M. Hoffmann
CURRENT CARDIOLOGY REPORTS
(2018)
Article
Mathematical & Computational Biology
Martin Jansen, Gerhard Puetz, Michael M. Hoffmann, Karl Winkler
BMC SYSTEMS BIOLOGY
(2019)
Article
Nutrition & Dietetics
Irene Pusceddu, Wolfgang Herrmann, Marcus E. Kleber, Hubert Scharnagl, Michael M. Hoffmann, Brigitte M. Winklhofer-Roob, Winfried Maerz, Markus Herrmann
EUROPEAN JOURNAL OF NUTRITION
(2020)
Article
Cardiac & Cardiovascular Systems
Christoph Koentges, Maria C. Cimolai, Katharina Pfeil, Dennis Wolf, Timoteo Marchini, Aleksandre Tarkhnishvili, Michael M. Hoffmann, Katja E. Odening, Philipp Diehl, Constantin von Zur Muehlen, Silvia Alvarez, Christoph Bode, Andreas Zirlik, Heiko Bugger
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
(2019)
Article
Pediatrics
Shwetha Kuthiroly, Dhanya Yesodharan, Natasha Radhakrishnan, Aparna Ganapathy, Ashraf U. Mannan, Michael M. Hoffmann, Sheela Nampoothiri
Summary: This study analyzed the clinical and molecular spectrum of Lipoprotein Lipase deficiency, highlighting the importance of a strict low-fat diet in managing the disorder effectively.
INDIAN JOURNAL OF PEDIATRICS
(2021)
Article
Cardiac & Cardiovascular Systems
Guenther Silbernagel, Hubert Scharnagl, Marcus E. Kleber, Michael M. Hoffmann, Graciela Delgado, Tatjana Stojakovic, Thomas Gary, Lingyao Zeng, Andreas Ritsch, Stephen Zewinger, Thimoteus Speer, Heribert Schunkert, Ulf Landmesser, Winfried Maerz, Tanja B. Grammer
Article
Biochemistry & Molecular Biology
Christine Contini, Julia Kuntz, Ulrich Massing, Irmgard Merfort, Karl Winkler, Gerhard Puetz
Summary: We investigated the effects of different lipids on the activity of the angiotensin II type 1 receptor (AT1R). The results showed that cells preincubated with Very low-density lipoprotein (VLDL) exhibited reduced calcium release triggered by angiotensin II, but further analysis revealed that this observation might be an artifact. Incubation with VLDL also decreased intracellular fura-2 levels and the maximal obtainable ratio of calcium ions in cells. These findings questioned the initial results and emphasized the importance of careful interpretation in fura-2 measurements.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2023)
Article
Clinical Neurology
Ernst Mayerhofer, Christoph Strecker, Heiko Becker, Marios K. Georgakis, Md Mesbah Uddin, Michael M. Hoffmann, Niroshan Nadarajah, Manja Meggendorfer, Torsten Haferlach, Jonathan Rosand, Pradeep Natarajan, Christopher D. Anderson, Andreas Harloff, Gregor Hoermann
Summary: Genetic screening in young stroke patients revealed a 3-fold higher prevalence of clonal hematopoiesis compared to the general population. About 4.4% of patients had high-risk clonal hematopoiesis and 1% had covert myeloproliferative neoplasms, requiring specific treatment. These findings highlight the diagnostic and therapeutic value of genetic screening in young stroke patients.
Meeting Abstract
Cardiac & Cardiovascular Systems
C. Koentges, E. Khan, S. Birkle, M. Hoelscher, K. Pfeil, J. Gollmer, M. M. Hoffmann, C. Bode, A. Zirlik, H. Bugger
EUROPEAN HEART JOURNAL
(2020)
Article
Medical Laboratory Technology
Gerhard Puetz, Manuela Mueller, Karl Winkler
JOURNAL OF LABORATORY MEDICINE
(2020)
Article
Cardiac & Cardiovascular Systems
Christoph Koentges, Mark E. Pepin, Carolyn Muesse, Katharina Pfeil, Sonia V. Viteri Alvarez, Natalie Hoppe, Michael M. Hoffmann, Katja E. Odening, Samuel Sossalla, Andreas Zirlik, Lutz Hein, Christoph Bode, Adam R. Wende, Heiko Bugger
BASIC RESEARCH IN CARDIOLOGY
(2018)
Meeting Abstract
Cardiac & Cardiovascular Systems
C. Koentges, E. Doerfer, K. Pfeil, S. Birkle, M. Hoelscher, M. M. Hoffmann, C. Bode, H. Bugger
EUROPEAN HEART JOURNAL
(2017)
Meeting Abstract
Cardiac & Cardiovascular Systems
C. Koentges, M. C. Cimolai, K. Pfeil, S. Alvarez, M. M. Hoffmann, C. Bode, H. Bugger
EUROPEAN HEART JOURNAL
(2017)
Meeting Abstract
Cardiac & Cardiovascular Systems
M. E. Hoelscher, C. Koentges, C. Muesse, S. Birkle, M. M. Hoffmann, C. Bode, H. Bugger
EUROPEAN HEART JOURNAL
(2017)